Sponsor pipeline

Tianjin Medical University General Hospital clinical trial pipeline

Get alerts when Tianjin Medical University General Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-08 NCT07865221 Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left… Not Yet Recruiting

Active trials by phase

Early Phase 1
2
Phase 1
1
Phase 1/2
3
Phase 2
4
Phase 2/3
2
Phase 3
3
Phase 4
2
Not charted: 7 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 17

Diabetes (2) · Glioblastoma (2) · Glioma (2) · Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Acute Lymphoblastic Leukemia (ALL) (1) · Acute Myeloid Leukemia (AML) (1) · Atrial Fibrillation (1) · Chronic Kidney Disease (1) · Heart Disease (1)

Get alerts when Tianjin Medical University General Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free